Reference Citation Analysis: Find an Article, Find a Category, Find a Journal, Find a Scholar

Download

Total Articles

2
(from Reference Citation Analysis)

Article PDFs (0)

Cited by > 0 (0)

Searched Name

dapagliflozin

Ranked By

Results Analysis

Year Published Analysis
Article Type Analysis
Publication Title Analysis
Category Analysis

Results Analysis

Indexed Articles

Year Published

Show more Refine

Article Type

Show more Refine

Article Statistics

Refine

MESH Headings

Show more Refine

First Author

Show more Refine

First Author Affiliations

Show more Refine

Authors

Show more Refine

Publication Titles

Show more Refine

Grant Agencies

Show more Refine

Countries/Regions

Show more Refine

Affiliations

Show more Refine

Corresponding Author Affiliations

Show more Refine

Category

Show more Refine

Number	Citation Analysis
1	Sotagliflozin (Inpefa) for heart failure. Med Lett Drugs Ther 2023;65:114-6. [PMID: 37460142 DOI: 10.58347/tml.2023.1681b] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Key Words] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 07/20/2023] Abstract Collapse Key Words Farxiga Inpefa Invokana Jardiance Steglatro adverse effects canagliflozin dapagliflozin dosage drug interactions efficacy empagliflozin ertugliflozin heart failure lactation pregnancy safety sotagliflozin Collapse MESH Headings Humans Hypoglycemic Agents/adverse effects Sodium-Glucose Transporter 2 Inhibitors/adverse effects Glycosides/adverse effects Heart Failure/diagnosis Heart Failure/drug therapy Diabetes Mellitus, Type 2/diagnosis Diabetes Mellitus, Type 2/drug therapy Benzhydryl Compounds Canagliflozin Collapse Grants Collapse Affiliation(s) Collapse
2	In brief: Expanded heart failure indication for dapagliflozin (Farxiga). Med Lett Drugs Ther 2023;65:101-2. [PMID: 37339090 DOI: 10.58347/tml.2023.1679c] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Key Words] [Subscribe] [Scholar Register] [Indexed: 06/22/2023] Abstract Collapse Key Words Farxiga Inpefa Invokana Jardiance Steglatro canagliflozin dapagliflozin dosage efficacy empagliflozin ertugliflozin heart failure sotagliflozin Collapse MESH Headings Collapse Grants Collapse Affiliation(s) Collapse